FDA Inspection 1219441 — Yichang Sanxia Pharmaceutical Co., Ltd.
The FDA completed an inspection of Yichang Sanxia Pharmaceutical Co., Ltd. on September 8, 2023 in Yichang. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 8, 2023
- Fiscal Year
- 2023
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Yichang (China)